Figure 6.
The effect of RLT-03 on tumor volume and weight. The EMT6 breast cancer xenograft model was established. Sixteen tumor bearing mice were divided into two groups (n = 8 each). (a) The tumor volume of the RLT-03 group was significantly reduced (p < 0.05∗). (b) The tumor weight of the RLT-03 group was significantly decreased (p < 0.05∗). (c) ELISA of IL-10 and IL-12 expressions in the serum. IL-10 and IL-12 expressions in the serum were the same as the control group (p > 0.05).